In India, the Central Drugs Standard Control Organisation (CDSCO) approved Mounjaro for adults with a BMI of 30 kg/m or higher, or 27 kg/m with weight-related conditions such as hypertension, dyslipidaemia or type 2 diabetes
De invloed van dit geneesmiddel op de levenskwaliteit (fysiek functioneren, sociaal functioneren, hoe je je op mentaal vlak voelt ...) is evenmin duidelijk
Plans should be requesting PBMs provide criteria for coverage when limiting to diabetes and hire a third-party auditor to ensure criteria are being followed
A proven approach to sustainable weight loss Reduce GLP-1 spend while empowering members to lose weight with or without medications
J King Saud Univ Sci 36(8):103326 Singla R, Jaitak V (2014) Shatavari (Asparagus racemosus Wild): a review on its cultivation, morphology, phytochemistry and pharmacological importance
No strategy for preserving the lean muscle mass that sustains your metabolic rate long after treatment ends